Guselkumab Induction Improves Moderate-to-Severe UC at Week 12 ...Middle East

Medscape - News
The drug was statistically superior to the placebo across all key endpoints in phase 2b study, regardless of patient response or intolerance to conventional and advanced therapies. MDedge News

Read More Details
Finally We wish PressBee provided you with enough information of ( Guselkumab Induction Improves Moderate-to-Severe UC at Week 12 )

Also on site :